США - англійська - NLM (National Library of Medicine)

a-s medication solutions - spironolactone (unii: 27o7w4t232) (spironolactone - unii:27o7w4t232) - spironolactone 25 mg - spironolactone tablets are indicated for treatment of nyha class iii-iv heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure. spironolactone tablets are usually administered in conjunction with other heart failure therapies. spironolactone tablets are indicated as add-on therapy for the treatment of hypertension, to lower blood pressure in patients who are not adequately controlled on other agents. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one dru

США - англійська - NLM (National Library of Medicine)

unit dose services - spironolactone (unii: 27o7w4t232) (spironolactone - unii:27o7w4t232) - spironolactone 25 mg - spironolactone is indicated in the management of: primary hyperaldosteronism for: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial. short-term preoperative treatment of patients with primary hyperaldosteronism. long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery. long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism). edematous conditions for patients with: congestive heart failure: for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures. spironolactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate. cirrhosis of the liver accompanied by edema and/or ascites: aldosterone levels may be exceptionally high in this condition. spi

США - англійська - NLM (National Library of Medicine)

bryant ranch prepack - spironolactone (unii: 27o7w4t232) (spironolactone - unii:27o7w4t232) - spironolactone 25 mg - spironolactone tablets are indicated for treatment of nyha class iii-iv heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure. spironolactone tablets are usually administered in conjunction with other heart failure therapies. spironolactone tablets are indicated as add-on therapy for the treatment of hypertension, to lower blood pressure in patients who are not adequately controlled on other agents. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one dru

США - англійська - NLM (National Library of Medicine)

unit dose services - spironolactone (unii: 27o7w4t232) (spironolactone - unii:27o7w4t232) - spironolactone 100 mg - spironolactone is indicated in the management of: primary hyperaldosteronism for: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial. short-term preoperative treatment of patients with primary hyperaldosteronism. long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery. long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism). edematous conditions for patients with: congestive heart failure: for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures. spironolactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate. cirrhosis of the liver accompanied by edema and/or ascites: aldosterone levels may be exceptionally high in this condition. spi

США - англійська - NLM (National Library of Medicine)

northwind pharmaceuticals, llc - spironolactone (unii: 27o7w4t232) (spironolactone - unii:27o7w4t232) - spironolactone 25 mg - spironolactone tablets are indicated in the management of: primary hyperaldosteronism for: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial. short-term preoperative treatment of patients with primary hyperaldosteronism. long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery. long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism). edematous conditions for patients with: congestive heart failure: for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures. spironolactone tablets are also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate. cirrhosis of the liver accompanied by edema and/or ascites: spironolactone levels may be exceptionally high in th

США - англійська - NLM (National Library of Medicine)

carilion materials management - spironolactone (unii: 27o7w4t232) (spironolactone - unii:27o7w4t232) - spironolactone 25 mg - spironolactone tablets, usp are indicated in the management of: for: primary hyperaldosteronism establishing the diagnosis of primary hyperaldosteronism by therapeutic trial. short-term preoperative treatment of patients with primary hyperaldosteronism. long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery. long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism). for patients with: edematous conditions for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures. spironolactone tablets, usp are also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate. congestive heart failure: spironolactone leve

США - англійська - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - spironolactone (unii: 27o7w4t232) (spironolactone - unii:27o7w4t232) - spironolactone 50 mg - spironolactone is indicated in the management of: primary hyperaldosteronism for: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial. short-term preoperative treatment of patients with primary hyperaldosteronism. long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery. long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism). edematous conditions for patients with: congestive heart failure: for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures. spironolactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate. cirrhosis of the liver accompanied by edema and/or ascites: aldosterone levels may be exceptionally high in this condition. spi

США - англійська - NLM (National Library of Medicine)

unit dose services - spironolactone (unii: 27o7w4t232) (spironolactone - unii:27o7w4t232) - spironolactone 50 mg - spironolactone is indicated in the management of: primary hyperaldosteronism for: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial. short-term preoperative treatment of patients with primary hyperaldosteronism. long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery. long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism). edematous conditions for patients with: congestive heart failure: for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures. spironolactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate. cirrhosis of the liver accompanied by edema and/or ascites: aldosterone levels may be exceptionally high in this condition. spi

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - folic acid, quantity: 95 microgram; calcium pantothenate, quantity: 4 mg; cyanocobalamin, quantity: 50 microgram; pyridoxine hydrochloride, quantity: 5 mg (equivalent: pyridoxine, qty 4.11 mg); calcium ascorbate dihydrate, quantity: 121.04 mg (equivalent: ascorbic acid, qty 100 mg); iron (ii) glycinate, quantity: 18.26 mg (equivalent: iron, qty 5 mg) - tablet, film coated - excipient ingredients: crospovidone; maltodextrin; purified talc; calcium hydrogen phosphate dihydrate; hypromellose; iron oxide red; titanium dioxide; citric acid; microcrystalline cellulose; isomalt; macrogol 6000; macrogol 400; tartaric acid; magnesium stearate; croscarmellose sodium; silicon dioxide - maintain/support energy levels ; maintain/support energy production ; relieve weariness/tiredness/fatigue/feeling of weakness ; aid/assist healthy red blood cell production ; helps maintain/support haemoglobin formation/synthesis ; maintain/support healthy immune system function ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral) within normal range

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

the better health company (australia) pty - iron (ii) glycinate, quantity: 120 mg (equivalent: iron, qty 24 mg); zinc citrate dihydrate, quantity: 1.56 mg (equivalent: zinc, qty 500 microgram); copper gluconate, quantity: 360 microgram (equivalent: copper, qty 50 microgram); ascorbic acid, quantity: 150 mg; citrus bioflavonoids extract, quantity: 50 mg; folic acid, quantity: 300 microgram; biotin, quantity: 150 microgram; thiamine hydrochloride, quantity: 25 mg (equivalent: thiamine, qty 22.3 mg); riboflavin, quantity: 20 mg; nicotinamide, quantity: 50 mg; calcium pantothenate, quantity: 30 mg (equivalent: pantothenic acid, qty 27.48 mg); pyridoxine hydrochloride, quantity: 25 mg (equivalent: pyridoxine, qty 20.57 mg); cyanocobalamin, quantity: 25 microgram; manganese amino acid chelate, quantity: 2.75 mg (equivalent: manganese, qty 550 microgram); potassium citrate, quantity: 11.05 mg (equivalent: potassium, qty 4 mg) - capsule, hard - excipient ingredients: citric acid; maltodextrin; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; silicon dioxide; titanium dioxide; hypromellose; purified water; pectin; carrageenan - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support collagen formation ; maintain/support energy levels ; helps convert (state food) into energy ; maintain/support heat/energy production/thermogenesis ; maintain/support healthy eye function ; maintain/support eye health ; maintain/support body mucous membrane health ; maintain/support general health and wellbeing ; maintain/support hair growth ; maintain/support hair health ; maintain/support healthy teeth ; aid/assist nail growth ; maintain/support nail health/strength/thickness ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; maintain/support healthy body tissues ; maintain/support bone health ; aid/assist healthy red blood cell production ; maintain/support red blood cell health ; maintain/support blood health ; helps maintain/support transport of oxygen in the body ; aid/assist/helps oxygen transport to body tissues ; helps maintain/support haemoglobin formation/synthesis ; maintain/support heart health ; maintain/support blood capillary health ; maintain/support blood vessel health ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support muscle function ; aid/assist/helps protein synthesis in the body ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; aids/assists the body to cope with environmental stress ; support healthy stress response in the body ; maintain/support nerve conduction ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system health ; maintain/support nervous system function ; maintains/support healthy foetal development ; maintain/support healthy pregnancy ; maintain/support maternal health ; maintain/support preconception health ; maintain/support skin health ; maintain/support wound healing